Glycolytic metabolic processes, particularly enzymes like HK2, PFKFB3, PKM2, PDH, LHD, and metabolites such as lactate, have emerged as potential predictors of stroke risk, development, and prognosis (39, 59, 196–199). This evidence concerns the gene PFKFB3 and stroke disorder.